STK11 and non-small cell lung carcinoma: LKB1-inactivating mutations are common in non-small cell lung cancer patients (NSCLC) through loss of heterozygosity on chromosome 19p that frequently accompanies nonsense and missense mutations as well as deletions (Fernandez et al, 2004).